arrow
A

A. M. Abdelhamid

biotechnology school
H指数:21
被引数:1,175

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diabetic Retinopathy in Focus: Update on Treatment Advances, Pharmaceutical Approaches, and New Technologies

糖尿病视网膜病变聚焦:治疗进展、药物疗法和新技术的更新

2025-10-010
OAAI
Innovative challenge for the inhibition of hepatocellular carcinoma progression by combined targeting of HSP90 and STAT3/HIF-1α signaling
2023-02-0121
OAAI
Canagliflozin-loaded chitosan-hyaluronic acid microspheres modulate AMPK/NF-κB/NLRP3 axis: A new paradigm in the rectal therapy of ulcerative colitis
2022-09-0127
PRE
Combining the HSP90 inhibitor TAS-116 with metformin effectively degrades the NLRP3 and attenuates inflammasome activation in rats: A new management paradigm for ulcerative colitis
2022-09-0117
PRE
Ambroxol, a mucolytic agent, boosts HO-1, suppresses NF-κB, and decreases the susceptibility of the inflamed rat colon to apoptosis: A new treatment option for treating ulcerative colitis
2022-08-1029
OA
Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application

二甲双胍联合Empagliflozin抑制肝细胞癌进展: 新应用的新兴方法

2022-01-0136
OAAI
Blunting p38 MAPKa and ERK1/2 activities by empagliflozin enhances the antifibrotic effect of metformin and augments its AMPK-induced NF-κB inactivation in mice intoxicated with carbon tetrachloride

empagliflozin钝化p38 MAPKa和ERK1/2活性增强了二甲双胍的抗纤维化作用,并增强了四氯化碳中毒小鼠中AMPK诱导的nf-κb失活

2021-12-0132
OAAI